IPC The Hospitalist Co. PT Raised to $52.00 (IPCM)
Jefferies Group lifted their price target on shares of IPC The Hospitalist Co. (NASDAQ:IPCM) from $46.00 to $52.00 in a research note issued on Friday, ARN reports. The firm currently has a “hold” rating on the stock. Jefferies Group’s price target suggests a potential downside of 4.59% from the company’s current price.
In other IPC The Hospitalist Co. news, Insider Devra Shapiro sold 5,000 shares of the company’s stock on the open market in a transaction that occurred on Monday, October 14th. The stock was sold at an average price of $50.78, for a total value of $253,900.00. Following the transaction, the insider now directly owns 2,645 shares in the company, valued at approximately $134,313. The transaction was disclosed in a document filed with the SEC, which is available at this link.
Shares of IPC The Hospitalist Co. (NASDAQ:IPCM) opened at 54.50 on Friday. IPC The Hospitalist Co. has a 52 week low of $33.10 and a 52 week high of $55.49. The stock has a 50-day moving average of $52.04 and a 200-day moving average of $48.39. The company has a market cap of $918.0 million and a price-to-earnings ratio of 22.59.
IPC The Hospitalist Co. (NASDAQ:IPCM) last issued its quarterly earnings data on Thursday, October 24th. The company reported $0.52 EPS for the quarter, meeting the Thomson Reuters consensus estimate of $0.52. The company had revenue of $149.10 million for the quarter, compared to the consensus estimate of $147.73 million. During the same quarter in the prior year, the company posted $0.46 earnings per share. The company’s quarterly revenue was up 16.8% on a year-over-year basis. On average, analysts predict that IPC The Hospitalist Co. will post $2.19 earnings per share for the current fiscal year.
A number of other firms have also recently commented on IPCM. Analysts at Deutsche Bank raised their price target on shares of IPC The Hospitalist Co. from $52.00 to $54.00 in a research note to investors on Friday. Separately, analysts at Dougherty & Co raised their price target on shares of IPC The Hospitalist Co. from $53.00 to $60.00 in a research note to investors on Friday. They now have a “buy” rating on the stock. Five research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. IPC The Hospitalist Co. has a consensus rating of “Hold” and a consensus price target of $54.13.
IPC The Hospitalist Company, Inc (NASDAQ:IPCM) is a provider of hospitalist services in the United States.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.